Copyright Clearance Center, Inc. (CCC), a leader in advancing copyright, accelerating knowledge, and powering innovation, recently hosted an invitation-only RightFind Roundtable with a select group of emerging life sciences customers. The two-day virtual event was comprised of a series of in-depth discussions about the changing information and data needs unique to these organizations.
RightFind is CCC’s award-winning research solution for hundreds of global R&D teams and other corporate content users from the smallest emerging life sciences company to the largest global R&D organizations in the world. It provides centralized seamless access to high-value content from subscriptions, licenses, and document delivery through intuitive software and services. Named ‘Best E-Discovery Solution’ by KMWorld in its inaugural Readers’ Choice Awards, RightFind is comprised of application modules that integrate seamlessly with CCC’s annual copyright licenses.
Since the early days of the pandemic, CCC has been committed to supporting global research efforts. CCC created a collection in RightFind of open-to-read content covering COVID and related diseases, which currently includes more than 175,000 articles and preprints. The CCC team continues to amplify the work of publishers, data creators, and data aggregators who are contributing to the common good by providing visualizations, dashboards, and access to datasets related to COVID-19.
With 40 years of experience working with content creators and users, CCC has a long history of building efficient solutions to address industry challenges. Led by content workflow experts with experience helping research organizations around the globe, CCC processes data feeds from nearly all major publishing houses and metadata aggregators accounting for more than 140M unique records per year across a wide range of industries. CCC also manages millions of rights and helps to promote collaboration and simplify copyright compliance.
Click here to read the original press release.
